The Goldman Sachs Group started coverage on shares of Coloplast A/S (OTCMKTS:CLPBY – Free Report) in a report published on Tuesday morning, FlyOnTheWall reports. The firm issued a neutral rating on the stock. Other research analysts have also recently issued reports about the stock. Morgan Stanley cut shares of Coloplast A/S from an overweight rating […]
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) has been given an average rating of “Hold” by the six brokerages that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and one has given a buy recommendation to the company. A […]
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) and Psykey (OTCMKTS:CEOS – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, risk, profitability, valuation and dividends. Institutional and Insider Ownership 0.1% of Coloplast A/S shares […]
Coloplast A/S (OTCMKTS:CLPBF – Get Free Report) was the recipient of a significant drop in short interest in June. As of June 30th, there was short interest totalling 538,400 shares, a drop of 16.0% from the June 15th total of 641,200 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio […]
DNB Markets upgraded shares of Coloplast A/S (OTCMKTS:CLPBY – Free Report) from a hold rating to a buy rating in a research note issued to investors on Monday, FlyOnTheWall reports. CLPBY has been the subject of a number of other reports. Morgan Stanley cut shares of Coloplast A/S from an overweight rating to an equal […]